US Edition5 Articles
5 Articles
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug - Overpasses For America
Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee prescription coverage for Americans. Employers pay lower drug prices but their workers are blocked from getting competin…
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
(New York Times) – CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients. Tens of thousands of Americans will soon be forced by their health insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen,…
Reasons Patients Must Transition to Second-Line Obesity Medications
Soon, tens of thousands of Americans will be compelled to transition from well-known obesity medications to alternatives that are likely to yield less effective weight loss, thanks to decisions made by Health’s insurance providers. This situation exemplifies the consequences of a clandestine agreement between a pharmaceutical company and an intermediary known as a pharmacy benefits [...] Source The post Reasons Patients Must Transition to Second…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
